BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

251 related articles for article (PubMed ID: 12210870)

  • 1. Riluzole prolongs survival time and alters nuclear inclusion formation in a transgenic mouse model of Huntington's disease.
    Schiefer J; Landwehrmeyer GB; Lüesse HG; Sprünken A; Puls C; Milkereit A; Milkereit E; Kosinski CM
    Mov Disord; 2002 Jul; 17(4):748-57. PubMed ID: 12210870
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Partial resistance to malonate-induced striatal cell death in transgenic mouse models of Huntington's disease is dependent on age and CAG repeat length.
    Hansson O; Castilho RF; Korhonen L; Lindholm D; Bates GP; Brundin P
    J Neurochem; 2001 Aug; 78(4):694-703. PubMed ID: 11520890
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Transgenic mice expressing mutated full-length HD cDNA: a paradigm for locomotor changes and selective neuronal loss in Huntington's disease.
    Reddy PH; Charles V; Williams M; Miller G; Whetsell WO; Tagle DA
    Philos Trans R Soc Lond B Biol Sci; 1999 Jun; 354(1386):1035-45. PubMed ID: 10434303
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The metabotropic glutamate receptor 5 antagonist MPEP and the mGluR2 agonist LY379268 modify disease progression in a transgenic mouse model of Huntington's disease.
    Schiefer J; Sprünken A; Puls C; Lüesse HG; Milkereit A; Milkereit E; Johann V; Kosinski CM
    Brain Res; 2004 Sep; 1019(1-2):246-54. PubMed ID: 15306259
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Time course of early motor and neuropathological anomalies in a knock-in mouse model of Huntington's disease with 140 CAG repeats.
    Menalled LB; Sison JD; Dragatsis I; Zeitlin S; Chesselet MF
    J Comp Neurol; 2003 Oct; 465(1):11-26. PubMed ID: 12926013
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Weight loss in Huntington disease increases with higher CAG repeat number.
    Aziz NA; van der Burg JM; Landwehrmeyer GB; Brundin P; Stijnen T; ; Roos RA
    Neurology; 2008 Nov; 71(19):1506-13. PubMed ID: 18981372
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Paradoxical delay in the onset of disease caused by super-long CAG repeat expansions in R6/2 mice.
    Morton AJ; Glynn D; Leavens W; Zheng Z; Faull RL; Skepper JN; Wight JM
    Neurobiol Dis; 2009 Mar; 33(3):331-41. PubMed ID: 19130884
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Reduced striatal acetylcholine efflux in the R6/2 mouse model of Huntington's disease: an examination of the role of altered inhibitory and excitatory mechanisms.
    Farrar AM; Callahan JW; Abercrombie ED
    Exp Neurol; 2011 Dec; 232(2):119-25. PubMed ID: 21864528
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Transient and progressive electrophysiological alterations in the corticostriatal pathway in a mouse model of Huntington's disease.
    Cepeda C; Hurst RS; Calvert CR; Hernández-Echeagaray E; Nguyen OK; Jocoy E; Christian LJ; Ariano MA; Levine MS
    J Neurosci; 2003 Feb; 23(3):961-9. PubMed ID: 12574425
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Changes in cortical and striatal neurons predict behavioral and electrophysiological abnormalities in a transgenic murine model of Huntington's disease.
    Laforet GA; Sapp E; Chase K; McIntyre C; Boyce FM; Campbell M; Cadigan BA; Warzecki L; Tagle DA; Reddy PH; Cepeda C; Calvert CR; Jokel ES; Klapstein GJ; Ariano MA; Levine MS; DiFiglia M; Aronin N
    J Neurosci; 2001 Dec; 21(23):9112-23. PubMed ID: 11717344
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A critical window of CAG repeat-length correlates with phenotype severity in the R6/2 mouse model of Huntington's disease.
    Cummings DM; Alaghband Y; Hickey MA; Joshi PR; Hong SC; Zhu C; Ando TK; André VM; Cepeda C; Watson JB; Levine MS
    J Neurophysiol; 2012 Jan; 107(2):677-91. PubMed ID: 22072510
    [TBL] [Abstract][Full Text] [Related]  

  • 12. R6/2 neurons with intranuclear inclusions survive for prolonged periods in the brains of chimeric mice.
    Reiner A; Del Mar N; Deng YP; Meade CA; Sun Z; Goldowitz D
    J Comp Neurol; 2007 Dec; 505(6):603-29. PubMed ID: 17948889
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Transgenic models of Huntington's disease.
    Sathasivam K; Hobbs C; Mangiarini L; Mahal A; Turmaine M; Doherty P; Davies SW; Bates GP
    Philos Trans R Soc Lond B Biol Sci; 1999 Jun; 354(1386):963-9. PubMed ID: 10434294
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Huntington's disease intranuclear inclusions contain truncated, ubiquitinated huntingtin protein.
    Sieradzan KA; Mechan AO; Jones L; Wanker EE; Nukina N; Mann DM
    Exp Neurol; 1999 Mar; 156(1):92-9. PubMed ID: 10192780
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dendritic spine pathology and deficits in experience-dependent dendritic plasticity in R6/1 Huntington's disease transgenic mice.
    Spires TL; Grote HE; Garry S; Cordery PM; Van Dellen A; Blakemore C; Hannan AJ
    Eur J Neurosci; 2004 May; 19(10):2799-807. PubMed ID: 15147313
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Increased calbindin-D28k immunoreactivity in striatal projection neurons of R6/2 Huntington's disease transgenic mice.
    Sun Z; Wang HB; Deng YP; Lei WL; Xie JP; Meade CA; Del Mar N; Goldowitz D; Reiner A
    Neurobiol Dis; 2005 Dec; 20(3):907-17. PubMed ID: 15990326
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The selective vulnerability of nerve cells in Huntington's disease.
    Sieradzan KA; Mann DM
    Neuropathol Appl Neurobiol; 2001 Feb; 27(1):1-21. PubMed ID: 11298997
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dopamine-dependent long term potentiation in the dorsal striatum is reduced in the R6/2 mouse model of Huntington's disease.
    Kung VW; Hassam R; Morton AJ; Jones S
    Neuroscience; 2007 Jun; 146(4):1571-80. PubMed ID: 17478055
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inhibition of apoptosis signal-regulating kinase 1 reduces endoplasmic reticulum stress and nuclear huntingtin fragments in a mouse model of Huntington disease.
    Cho KJ; Lee BI; Cheon SY; Kim HW; Kim HJ; Kim GW
    Neuroscience; 2009 Nov; 163(4):1128-34. PubMed ID: 19646509
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Formation of neuronal intranuclear inclusions underlies the neurological dysfunction in mice transgenic for the HD mutation.
    Davies SW; Turmaine M; Cozens BA; DiFiglia M; Sharp AH; Ross CA; Scherzinger E; Wanker EE; Mangiarini L; Bates GP
    Cell; 1997 Aug; 90(3):537-48. PubMed ID: 9267033
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.